Alnylam Pharmaceuticals
ALNY
#641
Rank
C$45.50 B
Marketcap
$351.51
Share price
-1.30%
Change (1 day)
72.50%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Stock price history for Alnylam Pharmaceuticals (ALNY)

Highest end of day price: $433.81 CAD on 2024-10-16

Lowest end of day price: $5.70 CAD on 2004-08-16

Stock price history of Alnylam Pharmaceuticals from 2004 to 2025

Stock price for similar companies or competitors

Company Stock price Change 1d% Country
$25.56-6.35%๐Ÿ‡บ๐Ÿ‡ธ USA
$988.54-1.99%๐Ÿ‡บ๐Ÿ‡ธ USA
$146.10-5.18%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.53 0.57%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.82-6.67%๐Ÿ‡บ๐Ÿ‡ธ USA
$159.67 1.44%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$81.58 3.76%๐Ÿ‡ซ๐Ÿ‡ท France
$23.09-2.79%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel